| Eglinton Manner CarriePresident & CEO, Director · 20 transactions | — | 2.19M | 2.94M | 161.6K | — |
| Michels Douglas APresident & CEO, Director · 142 transactions | — | 660.9Kas of Mar 2018 | 2.50M | — | 1.69M |
| McGrath Kenneth JChief Financial Officer · 17 transactions | — | 589.6K | 460.1K | 218.3K | — |
| Weber Kathleen GallagherChief Product Officer · 52 transactions | — | 399.5Kas of Mar 2025 | 523.8K | — | 34.1K |
| Spair Ronald HCOO & CFO, Director · 101 transactions | — | 274.7K†as of Jun 2018 | 1.51M | 10.0K | 1.18M |
| Tang Stephen S PHDPresident and CEO · 35 transactions | — | 247.1Kas of Feb 2022 | 517.1K | 1.0K | 99.0K |
| Kenny John P.Director · 8 transactions | — | 209.7K | 163.4K | 47.7K | — |
| Pringle Roger LDirector · 27 transactions | — | 208.6K†as of May 2017 | 306.5K | 10.0K | 140.6K |
| Watson Douglas GDirector · 18 transactions | — | 188.0Kas of Nov 2016 | 303.9K | 10.0K | 100.0K |
| Anthony Michele MarieSVP Finance & CAO · 19 transactions | — | 185.8K | 163.8K | — | 1.8K |
| Gagliano Nancy JDirector · 17 transactions | — | 185.1K | 281.5K | 17.1K | — |
| Aspinall Mara G.Director · 18 transactions | — | 178.8Kas of May 2025 | 201.3K | 11.0K | — |
| Zezzo II AnthonyEVP &, BU Lead - Infectious · 41 transactions | — | 175.1Kas of Feb 2020 | 528.2K | — | 187.9K |
| Boyd Steven KyleDirector · 8 transactions | — | 163.2K | 89.7K | 75.0K | — |
| Marmora LelioDirector · 14 transactions | — | 148.5K | 194.8K | 7.0K | — |
| Formica P MichaelExec. VP & GM Cryo. Sys. Div. · 16 transactions | — | 147.9Kas of Aug 2009 | 119.7K | — | — |
| Shulkin DavidDirector · 13 transactions | — | 126.3Kas of May 2025 | 157.3K | — | — |
| Jerrett Jack ESVP General Counsel &, CCO · 100 transactions | — | 124.6Kas of Dec 2021 | 688.2K | 10.0K | 446.4K |
| Nibauer LisaPresident of Diagnostics · 7 transactions | — | 123.5Kas of May 2022 | 129.3K | — | — |
| McMahon Robert W.Director · 7 transactions | — | 123.1K | 159.8K | — | — |
| Cuca RobertoCFO · 16 transactions | — | 114.8Kas of May 2021 | 108.0K | 10.0K | — |
| Celano MichaelDirector · 34 transactions | — | 111.8Kas of Aug 2022 | 216.8K | 22.0K | 85.0K |
| Lancaster Ronny BDirector · 38 transactions | — | 104.8Kas of Aug 2022 | 263.3K | 75.0K | 194.6K |
| Gleason ScottInterim CFO/SVP IR · 3 transactions | — | 96.5Kas of May 2022 | 78.1K | — | — |
| Gallagher AgnieszkaGeneral Counsel &, CCO · 3 transactions | — | 90.6Kas of Feb 2022 | 90.6K | — | — |
| Datin James ADirector · 39 transactions | — | 82.1Kas of May 2024 | 116.2K | — | — |
| Bertrand John D.Director · 2 transactions | — | 79.8K | 79.8K | — | — |
| Kuna Mark LSee Remarks · 109 transactions | — | 68.9Kas of Oct 2018 | 572.9K | — | 420.7K |
| Hobbs Eamonn PDirector · 13 transactions | — | 61.5Kas of May 2022 | 74.0K | — | — |
| Patrick Charles WDirector, Director · 36 transactions | — | 58.4Kas of May 2020 | 165.8K | 15.0K | 87.5K |
| Miller Michele MarieVP, Finance and Controller · 17 transactions | — | 58.2Kas of Feb 2022 | 64.2K | — | — |
| Zack Joseph EExec. VP - Mktg. & Sales · 17 transactions | — | 55.9Kas of Feb 2008 | 73.5K | — | 11.3K |
| Lee Stephen RExec. VP & CSO · 47 transactions | — | 55.8K†as of Feb 2014 | 324.0K | — | 233.1K |
| Reed MichaelSVP R&D and CSO · 14 transactions | — | 49.2Kas of Apr 2019 | 71.3K | — | — |
| Ostrov Gerald MDirector · 3 transactions | — | 39.3Kas of May 2014 | 39.3K | — | — |
| Goldstein JackDirector · 5 transactions | — | 36.0Kas of Feb 2011 | 45.0K | — | — |
| Smith BrianEVP & BU Lead - Molecular · 11 transactions | — | 28.1Kas of Feb 2018 | 29.0K | — | 32.2K |
| Whitaker Anne ClemDirector · 4 transactions | — | 23.8Kas of May 2023 | 30.6K | — | — |
| Sarin AradhanaDirector, Director · 3 transactions | — | 16.9Kas of May 2019 | 18.5K | — | — |
| Whitters EricSVP, Research and Development · 2 transactions | — | 9.9Kas of Feb 2015 | 7.1K | — | — |